Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
003520.KS Stock Summary
In the News
003520.KS Financial details
Company Rating
Neutral
Market Cap
401.45B
Income
-3.88B
Revenue
234.9B
Book val./share
490.08
Cash/share
55.81
Dividend
-
Dividend %
-
Employees
574
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
-19.31
Forward P/E
-
PEG
2.35
P/S
1.75
P/B
4.36
P/C
38.52
P/FCF
-23.01
Quick Ratio
-
Current Ratio
1.67
Debt / Equity
0.74
LT Debt / Equity
0.45
-
-
EPS (TTM)
-21.35
EPS next Y
-
EPS next Q
-
EPS this Y
-82.35%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
1.27%
Revenue Q/Q
8.32%
EPS Q/Q
32.99%
-
-
-
-
SMA20
3.77%
SMA50
-1.03%
SMA100
0.86%
Inst Own
-
Inst Trans
-
ROA
-9%
ROE
-22%
ROC
-0.02%
Gross Margin
30%
Oper. Margin
-1%
Profit Margin
-9%
Payout
-
Shs Outstand
182.89M
Shs Float
86.95M
-
-
-
-
Target Price
-
52W Range
1960.0-3775.0
52W High
-43.05%
52W Low
+9.69%
RSI
58
Rel Volume
1.65
Avg Volume
334.52K
Volume
550.41K
Perf Week
6.44%
Perf Month
6.17%
Perf Quarter
-6.52%
Perf Half Y
-6.52%
-
-
-
-
Beta
0.895
-
-
Volatility
31.9%, 52.72%
Prev Close
1.42%
Price
2150
Change
-1.38%
003520.KS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.23K | 1.14K | 1.07K | 1.19K | 1.28K | |
Net income per share | 28 | -0.73 | -63.33 | -120.08 | -21.19 | |
Operating cash flow per share | 51.67 | 79.27 | 45.75 | -63.48 | -68.34 | |
Free cash flow per share | -5.99 | 44.8 | -16.14 | -135.65 | -124.32 | |
Cash per share | -4.03 | -9.9 | -9.71 | -3.85 | 55.81 | |
Book value per share | 644.35 | 625.68 | 573.48 | 491.38 | 490.08 | |
Tangible book value per share | 632.03 | 617.12 | 565.6 | 476.73 | 477.42 | |
Share holders equity per share | 644.35 | 625.68 | 573.48 | 491.38 | 490.08 | |
Interest debt per share | 83.81 | 41.21 | 72.55 | 219.02 | 379.17 | |
Market cap | 1191.01B | 1470.46B | 967.5B | 635.55B | 397.79B | |
Enterprise value | 1204.99B | 1477.31B | 980.1B | 674.19B | 457.47B | |
P/E ratio | 236.79 | -11.05K | -83.53 | -28.94 | -102.64 | |
Price to sales ratio | 5.4 | 7.05 | 4.93 | 2.91 | 1.69 | |
POCF ratio | 128.31 | 101.43 | 115.62 | -54.74 | -31.82 | |
PFCF ratio | -1.11K | 179.48 | -327.74 | -25.62 | -17.5 | |
P/B Ratio | 10.29 | 12.85 | 9.22 | 7.07 | 4.44 | |
PTB ratio | 10.29 | 12.85 | 9.22 | 7.07 | 4.44 | |
EV to sales | 5.46 | 7.09 | 5 | 3.09 | 1.95 | |
Enterprise value over EBITDA | 67.61 | 174.32 | -152.9 | -49.31 | 38.73 | |
EV to operating cash flow | 129.81 | 101.9 | 117.13 | -58.07 | -36.6 | |
EV to free cash flow | -1.12K | 180.32 | -332.01 | -27.17 | -20.12 | |
Earnings yield | 0 | 0 | -0.01 | -0.03 | -0.01 | |
Free cash flow yield | 0 | 0.01 | 0 | -0.04 | -0.06 | |
Debt to equity | 0.13 | 0.06 | 0.12 | 0.44 | 0.74 | |
Debt to assets | 0.07 | 0.04 | 0.07 | 0.19 | 0.29 | |
Net debt to EBITDA | 0.78 | 0.81 | -1.96 | -2.83 | 5.05 | |
Current ratio | 2.8 | 3.27 | 1.86 | 2.06 | 1.69 | |
Interest coverage | 23.36 | 2.74 | -66.41 | -10 | 1.06 | |
Income quality | 1.85 | -108.91 | -0.72 | 0.53 | 3.23 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | |
Research and developement to revenue | 0.06 | 0.07 | 0.07 | 0.07 | 0.05 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | -1.12 | -0.43 | -1.35 | 1.14 | 0.82 | |
Capex to revenue | -0.05 | -0.03 | -0.06 | -0.06 | -0.04 | |
Capex to depreciation | -1.35 | -0.81 | -1.53 | -1.7 | -1.18 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 637.13 | 101.23 | 903.97 | 1.15K | 483.39 | |
ROIC | 0.04 | 0 | -0.09 | -0.05 | 0.02 | |
Return on tangible assets | 0.03 | 0 | -0.06 | -0.11 | -0.02 | |
Graham Net | -91.29 | -82.35 | -186.66 | -272.83 | -301.52 | |
Working capital | 71.54B | 68.53B | 41.36B | 52.56B | 51.51B | |
Tangible asset value | 113.54B | 112.87B | 103.44B | 87.19B | 87.32B | |
Net current asset value | 26.64B | 25.01B | 478.24M | -11.02B | -10.4B | |
Invested capital | 0.13 | 0.06 | 0.12 | 0.44 | 0.74 | |
Average receivables | 57.37B | 50.49B | 47.81B | 51.2B | 53.61B | |
Average payables | 16.47B | 11.86B | 12.83B | 18.14B | 20.05B | |
Average inventory | 51.9B | 53.7B | 45.54B | 44.06B | 55.22B | |
Days sales outstanding | 90.58 | 81.01 | 91.89 | 88.67 | 84.16 | |
Days payables outstanding | 35.38 | 27.26 | 41.17 | 49.17 | 43.2 | |
Days of inventory on hand | 145.12 | 139.07 | 104.78 | 115.13 | 137.99 | |
Receivables turnover | 4.03 | 4.51 | 3.97 | 4.12 | 4.34 | |
Payables turnover | 10.32 | 13.39 | 8.87 | 7.42 | 8.45 | |
Inventory turnover | 2.52 | 2.62 | 3.48 | 3.17 | 2.65 | |
ROE | 0.04 | 0 | -0.11 | -0.24 | -0.04 | |
Capex per share | -57.66 | -34.47 | -61.89 | -72.17 | -55.98 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 336.73 | 351.61 | 311.84 | 324.61 | 351.64 | |
Net income per share | -96.07 | -1 | -9.19 | -4.79 | -6.37 | |
Operating cash flow per share | -44.25 | -22.16 | 17.81 | -38.99 | -18.92 | |
Free cash flow per share | -55.98 | -34.99 | 5.59 | -46.42 | -44.43 | |
Cash per share | -3.98 | -16.19 | -7.11 | -3.18 | 55.81 | |
Book value per share | 508.03 | 582.7 | 482.12 | 477.51 | 490.08 | |
Tangible book value per share | 492.89 | 565.7 | 468.53 | 464.67 | 477.42 | |
Share holders equity per share | 508.03 | 582.7 | 482.12 | 477.51 | 490.08 | |
Interest debt per share | 224.04 | 299 | 255.83 | 311.87 | 368.81 | |
Market cap | 614.72B | 452.32B | 450.83B | 420.65B | 397.79B | |
Enterprise value | 653.36B | 497.51B | 495.6B | 475.58B | 457.47B | |
P/E ratio | -9.04 | -733.75 | -67.08 | -120.11 | -85.32 | |
Price to sales ratio | 10.32 | 8.35 | 7.9 | 7.09 | 6.19 | |
POCF ratio | -78.53 | -132.47 | 138.43 | -58.99 | -114.93 | |
PFCF ratio | -62.07 | -83.87 | 440.96 | -49.55 | -48.95 | |
P/B Ratio | 6.84 | 5.04 | 5.11 | 4.82 | 4.44 | |
PTB ratio | 6.84 | 5.04 | 5.11 | 4.82 | 4.44 | |
EV to sales | 10.97 | 9.18 | 8.69 | 8.01 | 7.11 | |
Enterprise value over EBITDA | -44.63 | 196.77 | 28.76 | 26.27 | 96.52 | |
EV to operating cash flow | -83.46 | -145.71 | 152.18 | -66.69 | -132.17 | |
EV to free cash flow | -65.97 | -92.25 | 484.75 | -56.02 | -56.29 | |
Earnings yield | -0.03 | 0 | 0 | 0 | 0 | |
Free cash flow yield | -0.02 | -0.01 | 0 | -0.02 | -0.02 | |
Debt to equity | 0.44 | 0.51 | 0.52 | 0.65 | 0.74 | |
Debt to assets | 0.19 | 0.22 | 0.22 | 0.26 | 0.29 | |
Net debt to EBITDA | -2.64 | 17.87 | 2.6 | 3.03 | 12.59 | |
Current ratio | 2.06 | 2.65 | 1.83 | 1.67 | 1.69 | |
Interest coverage | -8.76 | 0.52 | -0.56 | 0.53 | 2.45 | |
Income quality | 0.46 | 22.16 | -1.94 | 8.14 | 2.97 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.31 | 0.3 | 0.01 | |
Research and developement to revenue | 0.08 | 0.05 | 0.05 | 0.06 | 0.02 | |
Intangibles to total assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Capex to operating cash flow | 0.27 | 0.58 | -0.69 | 0.19 | 1.35 | |
Capex to revenue | -0.03 | -0.04 | -0.04 | -0.02 | -0.07 | |
Capex to depreciation | -0.98 | -0.9 | -1.02 | -0.63 | -2.18 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.05K | 114.5 | 315.69 | 226.79 | 265.09 | |
ROIC | -0.02 | 0 | 0 | 0 | 0.02 | |
Return on tangible assets | -0.08 | 0 | -0.01 | 0 | -0.01 | |
Graham Net | -282.07 | -360.29 | -316.87 | -330.38 | -301.52 | |
Working capital | 52.56B | 65.78B | 49.66B | 47.96B | 51.51B | |
Tangible asset value | 87.19B | 87.18B | 85.69B | 84.98B | 87.32B | |
Net current asset value | -11.02B | -12.03B | -12.8B | -13.31B | -10.4B | |
Invested capital | 0.44 | 0.51 | 0.52 | 0.65 | 0.74 | |
Average receivables | 51.38B | 52.16B | 50.2B | 52.33B | 54.86B | |
Average payables | 20.18B | 21.28B | 23.66B | 25.68B | 22.67B | |
Average inventory | 49.89B | 50.33B | 54.92B | 59.97B | 62.14B | |
Days sales outstanding | 80.15 | 85.17 | 77.5 | 84.21 | 75.79 | |
Days payables outstanding | 43.89 | 52.42 | 57.54 | 56.55 | 39.3 | |
Days of inventory on hand | 102.75 | 125.11 | 130.36 | 135.86 | 125.53 | |
Receivables turnover | 1.12 | 1.06 | 1.16 | 1.07 | 1.19 | |
Payables turnover | 2.05 | 1.72 | 1.56 | 1.59 | 2.29 | |
Inventory turnover | 0.88 | 0.72 | 0.69 | 0.66 | 0.72 | |
ROE | -0.19 | 0 | -0.02 | -0.01 | -0.01 | |
Capex per share | -11.73 | -12.84 | -12.22 | -7.43 | -25.51 |
003520.KS Frequently Asked Questions
What is Yungjin Pharm. Co., Ltd. stock symbol ?
Yungjin Pharm. Co., Ltd. is a KR stock and trading under the symbol 003520.KS
What is Yungjin Pharm. Co., Ltd. stock quote today ?
Yungjin Pharm. Co., Ltd. stock price is $2150 today.
Is Yungjin Pharm. Co., Ltd. stock public?
Yes, Yungjin Pharm. Co., Ltd. is a publicly traded company.